Of the 40 individuals with UBQLN2 mutations, three individuals had onset of symptoms prior to age 24; one with classical ALS findings, one with ALS combined with FTD, and one described as having a combination of upper motor neuron signs and dementia. This evidence concerns the gene UBQLN2 and amyotrophic lateral sclerosis.